We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA) (FRUTIGA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03223376
Recruitment Status : Active, not recruiting
First Posted : July 21, 2017
Last Update Posted : September 2, 2022
Sponsor:
Collaborator:
Sun Yat-sen University
Information provided by (Responsible Party):
Hutchmed ( Hutchison Medipharma Limited )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : November 2022